Opendata, web and dolomites

Savesight SIGNED

Contact lens embedded sensor for ocular hypertension and glaucoma monitoring

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Savesight project word cloud

Explore the words cloud of the Savesight project. It provides you a very rough idea of what is the project "Savesight" about.

blindness    patients    report    2026    invasive    full    international    healthcare    million    2022    prominent    aid    professionals    treatment    hypertension    2021    safety    form    stealthy    significantly    heavy    conventional    continuous    intraocular    24    pressure    single    proprietary    fraction    electrical    monitor    equal    caused    create    recognised    hour    patents    indirect    permanent    plans    elevated    iop    competitor    reliability    life    people    marketscope    edge    12    monitorization    progression    quality    market    contact    issue    cure    overcome    ocular    algorithms    technologies    111    mechanical    pending    scientific    angle    gt    glakolens    comfort    diagnose    chronic    medical    accuracy    revenues    grow    worldwide    sufficient    patient    billion    mainly    2040    clinic    view    burden    superior    glaucoma    sensor    cycle    lens    294    diurnal    cutting    monitoring    granted    steadily    competitors    rely    direct    accurately    enter    reduces   

Project "Savesight" data sheet

The following table provides information about the project.

Coordinator
GLAKOLENS BIYOMEDIKAL BIYOTEKNOLOJISANAYI VE TICARET ANONIM SIRKETI 

Organization address
address: BOGAZICI UNIVERSITY, KUZEY KAMPUS, TEKNOPARK 306, BEBEK YOLU SOKAK 2/5, RUMELI HISARI MAHALLESI
city: SARIYER, ISTANBUL
postcode: 34470
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Turkey [TR]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2020
 Duration (year-month-day) from 2020-01-01   to  2020-06-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    GLAKOLENS BIYOMEDIKAL BIYOTEKNOLOJISANAYI VE TICARET ANONIM SIRKETI TR (SARIYER, ISTANBUL) coordinator 50˙000.00

Map

 Project objective

Glaucoma affects over 70 million people worldwide (>12 million in Europe), and this number is expected to grow steadily to reach 111 million by 2040. Glaucoma is a chronic condition with no permanent cure and is the second leading cause of blindness. It significantly reduces the quality of life and presents a heavy burden on healthcare systems. Its most prominent and stealthy form, namely open-angle glaucoma, is mainly caused by chronic ocular hypertension (high intraocular pressure [IOP]). Conventional methods used to diagnose elevated IOP, monitor the progression of glaucoma and create treatment algorithms rely on a single IOP measurement conducted at the clinic. Due to the diurnal cycle of IOP, conventional methods do not provide sufficient and reliable information to evaluate the condition of the patients accurately. GlakoLens has been developing a non-invasive contact lens embedded sensor system that will aid medical professionals to overcome this issue by continuous 24-hour monitorization of the IOP changes. GlakoLens' proprietary technology (1 granted and 3 pending international patents) based on years of cutting-edge scientific research enables superior features for the patient (better comfort, electrical and mechanical safety, and full field-of-view) at a fraction of the cost of the only direct competitor in the market while providing better measurement accuracy and reliability. Four more indirect competitors have recognised the need in the market and are developing products using different technologies to address this need. According to a report by Marketscope, IOP monitoring market is expected to reach €1.5 billion by 2021. Glakolens plans to enter the market by the end of 2022, with estimated revenues equal to about €294.6 million in 2026.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SAVESIGHT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SAVESIGHT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Dyme (2019)

Dyme gives its users complete control over their financial situation. The Dyme application provides insight into users’ spending and subscriptions, and lets users cancel, negotiate, or switch any cont

Read More  

Presque (2019)

Smart Nursing Bra

Read More  

DeltaQon (2019)

IOT and cloud computing for online medical analysis service platform

Read More